ZYME Zymeworks Inc. - Common Stock
$27,70
Harga · Agu 19, 2026
Fundamental per Agu 6, 2026
Rentang 52M
$13–$30
87% of range
Peringkat Analis
BUY
18 analysts
Target Harga
$40
+46% upside
P/E (TTM)
-25.6
ROE
-26.9%
Margin Laba Bersih
-76.6%
Tentang Zymeworks Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Baca selengkapnya
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
ZYME Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$27.70
Kapitalisasi Pasar
$2.07B
P/E (TTM)
-25.6
EPS (TTM)
$-1.08
Pendapatan (TTM)
$106M
Imbal Hasil Dividen
—
ROE
-26.9%
D/E Utang/Ekuitas
—
Rentang 52M
$13 – $30
ZYME Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$106M
2020-12-31
→
2025-12-31
EPS
$-1.08
2020-12-31
→
2025-12-31
Arus Kas Bebas
$-35M
2023-12-31
→
2025-12-31
Margin
-76.6%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
ZYME
Median Rekan
P/E (TTM)
-25.6
—
P/S (TTM)
19.5
418.4
P/B
7.7
2.3
Price / FCF (Harga / FCF)
-59.9
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
ZYME
Median Rekan
Operating Margin (Margin Operasi)
-87.3%
—
Net Profit Margin (Margin Laba Bersih)
-76.6%
-549.8%
ROA
-20.0%
-41.8%
ROE
-26.9%
-54.1%
ROIC
-35.1%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
ZYME
Median Rekan
Current Ratio (Rasio Lancar)
5.9
12.6
Quick Ratio (Rasio Cepat)
1.1
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
ZYME
Median Rekan
Revenue YoY (Pendapatan YoY)
38.9%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
-36.4%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
22.2%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
ZYME
Median Rekan
ZYME Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
18 analis
- Beli Kuat 6 33,3%
- Beli 11 61,1%
- Tahan 1 5,6%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
12 analis · 2026-08-16
Median
$38.50
← Di bawah semua target
$27.70
Rendah
$31.00
Tinggi
$58.00
Target median
$38.50
+39,0%
Target rata-rata
$40.33
+45,6%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.01%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.62 | $-0.50 | -0.12% |
| 31 Maret 2026 | $-0.59 | $-0.20 | -0.39% |
| 31 Des. 2025 | $-0.55 | $-0.42 | -0.13% |
| 30 Sep. 2025 | $-0.26 | $-0.33 | 0.07% |
| 30 Juni 2025 | $0.03 | $-0.50 | 0.53% |
| 31 Maret 2025 | $-0.30 | $-0.42 | 0.12% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
Neraca 23
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
Arus Kas 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
Efisiensi 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | -150,871,069 | 75,767,778 | 75,337,168 | 75,171,020 | -152,889,276 | 76,128,531 | 76,392,593 | 76,214,833 | -135,733,099 | 70,575,773 | 67,281,028 | 66,739,308 | -129,002,888 | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | -152,966,654 | 75,775,214 | 77,378,449 | 75,226,387 | -152,922,738 | 76,157,101 | 76,396,217 | 76,248,158 | -135,739,304 | 70,575,773 | 67,284,511 | 66,742,030 | -128,961,927 | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
Neraca 23
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
Arus Kas 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $83M | $106M | · | $119M | $111M | $72M | · | $62M | $53M | $69M | · | $62M | $51M | $46M | · | $14M | |
| Net Income TTM | $-106M | $-84M | · | $-70M | $-88M | $-122M | · | $-128M | $-149M | $-136M | · | $-152M | $-188M | $-209M | · | $-246M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -18.2 | -22.4 | · | -18.6 | -10.9 | -7.4 | · | -7.3 | -4.1 | -5.4 | · | -2.8 | -3.1 | -2.8 | · | -1.5 | |
| P/S | 22.4 | 17.3 | · | 10.7 | 8.5 | 11.4 | · | 14.1 | 11.4 | 10.8 | · | 7.0 | 11.5 | 12.7 | · | 26.4 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| P / FCF | · | -39.9 | · | · | · | -242.1 | · | · | · | -19.6 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -5.5% | -4.5% | · | -5.4% | -9.2% | -13.4% | · | -13.6% | -24.4% | -18.6% | · | -35.6% | -32.6% | -35.9% | · | -67.2% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $106M | $76M | $76M | $412M | $27M |
| Margin Operasi % | -87.3% | -179.7% | -181.6% | — | — |
| Laba Bersih | $-81M | $-123M | $-119M | $124M | $-212M |
| EPS Dilusian | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 5.9 | 3.4 | 7.4 | — | — |
| Rasio Cepat | 1.1 | 1.4 | 7.1 | — | — |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-35M | $-112M | $-121M | — | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 218 pengaju · $1.5B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 30 (-4 vs Kuartal sebelumnya) | 29 (-2 vs Kuartal sebelumnya) | 56 (-17 vs Kuartal sebelumnya) | 68 (+9 vs Kuartal sebelumnya) | +2.6M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600.445.942 | 22.970.388 | 39,27% | Saham |
| Rubric Capital Management LP | $182.980.000 | 7.000.000 | 11,97% | Saham |
| PERCEPTIVE ADVISORS LLC | $109.342.391 | 4.182.953 | 7,15% | Saham |
| BVF INC/IL | $95.388.572 | 3.649.142 | 6,24% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.752.208 | 1.558.998 | 2,67% | Saham |
| Assenagon Asset Management S.A. | $32.727.986 | 1.252.027 | 2,14% | Saham |
| Nextech Invest Ltd. | $29.118.548 | 1.113.946 | 1,90% | Saham |
| STATE STREET CORP | $28.445.966 | 1.088.216 | 1,86% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $24.486.776 | 936.755 | 1,60% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23.259.000 | 889.802 | 1,52% | Saham |
| CITADEL ADVISORS LLC | $21.330.894 | 816.025 | 1,40% | Saham |
| FMR LLC | $18.355.822 | 702.212 | 1,20% | Saham |
| Prosight Management, LP | $17.629.705 | 674.434 | 1,15% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $16.322.460 | 624.447 | 1,07% | Saham |
| Nextech Invest Ltd. | $16.308.169 | 1.113.946 | 1,07% | Saham |
| Qube Research & Technologies Ltd | $15.516.443 | 593.590 | 1,01% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.332.236 | 510.032 | 0,87% | Saham |
| Redmile Group, LLC | $12.851.836 | 491.654 | 0,84% | Saham |
| Capricorn Fund Managers Ltd | $12.717.868 | 486.529 | 0,83% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.939.512 | 418.497 | 0,72% | Saham |
| Hillsdale Investment Management Inc. | $10.009.581 | 382.922 | 0,65% | Saham |
| GOLDMAN SACHS GROUP INC | $9.345.338 | 357.511 | 0,61% | Saham |
| FIRST TRUST ADVISORS LP | $8.897.088 | 340.363 | 0,58% | Saham |
| Granahan Investment Management, LLC | $8.787.144 | 336.157 | 0,57% | Saham |
| Pictet Asset Management Holding SA | $7.446.189 | 308.187 | 0,49% | Saham |
| PICTON MAHONEY ASSET MANAGEMENT | $7.092.908 | 271.343 | 0,46% | Saham |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.849.243 | 223.766 | 0,38% | Saham |
| SummitTX Capital, L.P. | $5.510.364 | 210.802 | 0,36% | Saham |
| Man Group plc | $5.509.763 | 210.779 | 0,36% | Saham |
| BANK OF AMERICA CORP /DE/ | $5.182.437 | 198.257 | 0,34% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.066.835 | 155.579 | 0,27% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.984.154 | 152.416 | 0,26% | Saham |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.960.132 | 151.497 | 0,26% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.800.390 | 145.386 | 0,25% | Saham |
| D. E. Shaw & Co., Inc. | $3.785.255 | 144.807 | 0,25% | Saham |
| DIADEMA PARTNERS LP | $3.715.330 | 142.132 | 0,24% | Saham |
| BlackRock, Inc. | $3.614.744 | 138.284 | 0,24% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.408.656 | 130.400 | 0,22% | Opsi beli |
| CITIGROUP INC | $3.364.872 | 128.725 | 0,22% | Saham |
| XTX Topco Ltd | $3.290.425 | 125.877 | 0,22% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $3.100.282 | 118.603 | 0,20% | Saham |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2.749.510 | 105.184 | 0,18% | Saham |
| AXA Investment Managers S.A. | $2.705.745 | 158.416 | 0,18% | Saham |
| Manatuck Hill Partners, LLC | $2.614.000 | 100.000 | 0,17% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.451.932 | 93.800 | 0,16% | Opsi jual |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $2.321.232 | 88.800 | 0,15% | Saham |
| MACKENZIE FINANCIAL CORP | $2.293.654 | 87.745 | 0,15% | Saham |
| VANGUARD GROUP INC | $2.251.979 | 85.529 | 0,15% | Saham |
| Y-Intercept (Hong Kong) Ltd | $2.181.514 | 83.455 | 0,14% | Saham |
| LMR Partners LLP | $2.156.550 | 82.500 | 0,14% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $2.127.587 | 81.392 | 0,14% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.094.337 | 80.120 | 0,14% | Saham |
| TEMA ETFS LLC | $2.000.422 | 75.975 | 0,13% | Saham |
| RHUMBLINE ADVISERS | $1.962.211 | 75.066 | 0,13% | Saham |
| Swiss National Bank | $1.939.588 | 74.200 | 0,13% | Saham |
| MARTINGALE ASSET MANAGEMENT L P | $1.915.592 | 73.282 | 0,13% | Saham |
| TWO SIGMA INVESTMENTS, LP | $1.878.786 | 71.874 | 0,12% | Saham |
| Dana Investment Advisors, Inc. | $1.873.192 | 71.660 | 0,12% | Saham |
| CREDIT AGRICOLE S A | $1.855.940 | 71.000 | 0,12% | Saham |
| Fisher Asset Management, LLC | $1.850.057 | 70.775 | 0,12% | Saham |
| SEGALL BRYANT & HAMILL, LLC | $1.747.093 | 66.836 | 0,11% | Saham |
| Verdad Advisers, LP | $1.743.224 | 66.688 | 0,11% | Saham |
| Susquehanna Portfolio Strategies, LLC | $1.705.583 | 65.248 | 0,11% | Saham |
| Campbell & CO Investment Adviser LLC | $1.591.246 | 60.874 | 0,10% | Saham |
| ALLIANCEBERNSTEIN L.P. | $1.399.636 | 55.896 | 0,09% | Saham |
| CITADEL ADVISORS LLC | $1.364.508 | 52.200 | 0,09% | Opsi beli |
| Virtus Investment Advisers, LLC | $1.328.566 | 50.825 | 0,09% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $1.272.365 | 48.675 | 0,08% | Saham |
| Quantinno Capital Management LP | $1.245.362 | 47.642 | 0,08% | Saham |
| WELLS FARGO & COMPANY/MN | $1.122.164 | 42.929 | 0,07% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $1.111.577 | 42.524 | 0,07% | Saham |
| Bank of New York Mellon Corp | $1.076.785 | 41.193 | 0,07% | Saham |
| MARSHALL WACE, LLP | $1.070.380 | 40.948 | 0,07% | Saham |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1.033.419 | 39.534 | 0,07% | Saham |
| Aquilo Capital Management, LLC | $1.006.181 | 84.482 | 0,07% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $965.141 | 36.922 | 0,06% | Saham |
| TUDOR INVESTMENT CORP ET AL | $953.352 | 36.471 | 0,06% | Saham |
| HighTower Advisors, LLC | $943.654 | 36.100 | 0,06% | Saham |
| Persistent Asset Partners Ltd | $939.341 | 35.935 | 0,06% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $936.221 | 37.389 | 0,06% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $904.653 | 34.608 | 0,06% | Saham |
| HighVista Strategies LLC | $889.100 | 34.013 | 0,06% | Saham |
| COMMONWEALTH EQUITY SERVICES, LLC | $837.838 | 32.052 | 0,05% | Saham |
| TWO SIGMA ADVISERS, LP | $827.157 | 31.415 | 0,05% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $807.360 | 30.886 | 0,05% | Saham |
| SBI Okasan Asset Management Co.Ltd. | $771.200 | 32.000 | 0,05% | Saham |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $735.529 | 27.935 | 0,05% | Saham |
| MetLife Investment Management, LLC | $728.888 | 27.884 | 0,05% | Saham |
| JOURNEY STRATEGIC WEALTH LLC | $722.304 | 28.846 | 0,05% | Saham |
| STRS OHIO | $692.710 | 26.500 | 0,05% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $686.933 | 26.279 | 0,04% | Saham |
| Brevan Howard Capital Management LP | $678.490 | 25.956 | 0,04% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $657.735 | 25.162 | 0,04% | Saham |
| RITHOLTZ WEALTH MANAGEMENT | $633.712 | 24.243 | 0,04% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $607.206 | 23.229 | 0,04% | Saham |
| Duncan Williams Asset Management, LLC | $577.563 | 22.095 | 0,04% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $564.049 | 21.578 | 0,04% | Saham |
| BARCLAYS PLC | $524.577 | 20.068 | 0,03% | Saham |
| SIMPLEX TRADING, LLC | $507.926 | 19.431 | 0,03% | Saham |
| Invesco Ltd. | $491.720 | 18.811 | 0,03% | Saham |
Orang dalam perusahaan 28 orang dalam · 12 pejabat · 17 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12 Jan. 2026 A | 226.842 | 0 | 4 | $-3.337.929 |
| Kristin Stafford | EVP, Chief Financial Officer | 6 April 2026 A | — | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 5 Jan. 2024 A | 6.503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10 Maret 2023 M | 17.032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 6 Juli 2026 A | 133.852 | 0 | 1 | $-138.740 |
| Paul R Schneider | EVP, General Counsel | 13 Mei 2026 A | — | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 9 April 2026 A | — | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 9 April 2026 A | — | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12 Jan. 2026 A | 48.497 | 0 | 3 | $-721.486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12 Jan. 2026 M | 26.708 | 0 | 2 | $-475.562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 6 Jan. 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10 Nov. 2022 M | 14.449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Direktur | 12 Jan. 2026 A | 488.500 | 0 | 0 | $0 |
| Alessandra Cesano | Direktur | 12 Jan. 2026 A | — | 0 | 0 | $0 |
| Carlos Campoy | Direktur | 12 Jan. 2026 A | — | 0 | 0 | $0 |
| Robert E Landry | Direktur | 12 Jan. 2026 A | — | 0 | 0 | $0 |
| Kelvin Neu | Direktur | 12 Jan. 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Direktur | 12 Jan. 2026 A | — | 0 | 0 | $0 |
| Brian N Cherry | Direktur | 12 Jan. 2026 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | Direktur | 17 Jan. 2025 P | 15.720.161 | 0 | 0 | $0 |
| Nancy Davidson | Direktur | 10 Des. 2024 A | — | 0 | 0 | $0 |
| Neil Gallagher | Direktur | 10 Des. 2024 A | — | 0 | 0 | $0 |
| Derek John Michael Miller | Direktur | 10 Des. 2024 A | — | 0 | 0 | $0 |
| Troy Cox | Direktur | 10 Des. 2024 A | — | 0 | 0 | $0 |
| Kenneth J. Hillan | Direktur | 7 Des. 2023 A | — | 0 | 0 | $0 |
| Hollings Renton | Direktur | 7 Des. 2023 A | — | 0 | 0 | $0 |
| Natalie Sacks | Direktur | 21 Des. 2022 A | — | 0 | 0 | $0 |
| Lota S. Zoth | Direktur | 21 Des. 2022 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 pengajuan | 19 Nov. 2025 | 30,70% | Amandemen | Kampanye dewan | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 pengajuan | 28 Des. 2022 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 41 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 1,51% | 105.615 NS | 31 Mei 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 10.832 NS | 30 April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,49% | 186.247 NS | 30 April 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 110.902 NS | 30 April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,15% | 16.669 NS | 31 Mei 2026 | N-PORT |
| SMMV · iShares Trust | 0,13% | 16.160 SH | 8 Agu 2026 | Harian |
| IBB · iShares Trust | 0,13% | 517.328 SH | 8 Agu 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 14.789 SH | 8 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 3.975 SH | 8 Agu 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 74.514 SH | 8 Agu 2026 | Harian |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 17.393 NS | 30 April 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.766 NS | 31 Mei 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 50.443 SH | 8 Agu 2026 | Harian |
| IWO · iShares Trust | 0,07% | 423.822 SH | 8 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 67.771 SH | 8 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,04% | 21.639 NS | 30 April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 270.692 SH | 8 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,04% | 189.866 NS | 30 April 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.183.337 SH | 8 Agu 2026 | Harian |
| ITWO · ProShares Trust | 0,03% | 2.345 NS | 31 Mei 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 10.887 NS | 31 Mei 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5.753 SH | 8 Agu 2026 | Harian |
| UWM · ProShares Trust | 0,02% | 1.834 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 16.794 NS | 30 April 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 1.999 SH | 8 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,01% | 5.891 SH | 8 Agu 2026 | Harian |
| URTY · ProShares Trust | 0,01% | 1.855 NS | 31 Mei 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3.008 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 110.298 SH | 8 Agu 2026 | Harian |
| TILT · FlexShares Trust | 0,01% | 5.236 NS | 30 April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.925 NS | 31 Mei 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 26.839 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 47 NS | 31 Mei 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.213 NS | 30 April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 72.902 NS | 30 April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.951 NS | 30 April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.256 SH | 8 Agu 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 8.364 NS | 30 April 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 130 NS | 30 April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.508.613 SH | 8 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.085 SH | 8 Agu 2026 | Harian |